1. Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021; 325:669–685.
2. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma: carcinoma sequence in large bowel. Lancet. 1978; 1:245–247.
3. Goto H, Oda Y, Murakami Y, et al. Proportion of de novo cancers among colorectal cancers in Japan. Gastroenterology. 2006; 131:40–46.
4. Leggett B, Whitehall V. Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology. 2010; 138:2088–2100.
5. Jass JR, Whitehall VL, Young J, et al. Emerging concepts in colorectal neoplasia. Gastroenterology. 2002; 123:862–876.
6. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012; 366:687–696.
7. Chung EJ, Lee JY, Choe J, et al. Colonic chicken skin mucosa is an independent endoscopic predictor of advanced colorectal adenoma. Intest Res. 2015; 13:318–325.
8. Lee YM, Song KH, Koo HS, et al. Colonic chicken skin mucosa surrounding colon polyps is an endoscopic predictive marker for colonic neoplastic polyps. Gut Liver. 2022; 16:754–763.
9. Zhang YJ, Wen W, Li F, et al. Chicken skin mucosa surrounding small colorectal cancer could be an endoscopic predictive marker of submucosal invasion. World J Gastrointest Oncol. 2023; 15:1062–1072.
10. Muto T, Kamiya J, Sawada T, et al. Clinical and histological studies on white spots of colonic mucosa around colonic polyps with special reference to diagnosis of early carcinoma. Gastroenterol Endosc. 1981; 23:241–247.
11. Hirota S, Hosobe S, Ikeda M, et al. Possibility of defense against colorectal tumor by foamy cells. J Clin Gastroenterol. 1997; 24:82–86.
12. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014; 370:1298–1306.
13. van Doorn SC, Klanderman RB, Hazewinkel Y, et al. Adenoma detection rate varies greatly during colonoscopy training. Gastrointest Endosc. 2015; 82:122–129.
14. Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015; 110:72–90.
15. Tanaka S, Saitoh Y, Matsuda T, et al. Evidence-based clinical practice guidelines for management of colorectal polyps. J Gastroenterol. 2015; 50:252–260.
16. Tanaka S, Saitoh Y, Matsuda T, et al. Evidence-based clinical practice guidelines for management of colorectal polyps. J Gastroenterol. 2021; 56:323–335.
17. Lambert R, Lightdale CJ. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003; 58:S3–S43.
18. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut. 2000; 47:251–255.
19. Schlemper RJ, Kato Y, Stolte M. Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol. 2001; 36:445–456.
20. Sakamoto T, Matsuda T, Nakajima T, et al. Clinicopathological features of colorectal polyps: evaluation of the ‘predict, resect and discard’ strategies. Colorectal Dis. 2013; 15:e295–e300.
21. Gschwantler M, Kriwanek S, Langner E, et al. High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol. 2002; 14:183–188.
22. O’Brien MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990; 98:371–379.
23. Lieberman DA, Weiss DG, Harford WV, et al. Five-year colon surveillance after screening colonoscopy. Gastroenterology. 2007; 133:1077–1085.
24. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006; 66:605–612.
25. Wagener S, Shankar KR, Turnock RR, et al. Colonic transit time: what is normal? J Pediatr Surg. 2004; 39:166–169.